Talk im Cube: Female Entrepreneurship - A Panel Discussion (in English)
with
Anthea Wirges, CARTemis Therapeutics GmbH
Elisa Kieback, t-knife GmbH
Lucile Bonnin, Cambrium GmbH
Merle Fuchs, Pramomolecular GmbH
Petya Jordan, Postdoc Center Adlershof, HU Berlin
Stefanie Reichelt, Carbon 13 & University of Cambridge (Moderation)
Target audience
Founders & scientists from start-ups, small and medium-sized life science companies and scientific institutions
Costs
Participation is free of charge.
Registration through this website clicking "Verbindlich Buchen" is requested.
Where
BerlinBioCube (D95), Campus Berlin-Buch, Robert-Rössle-Straße 10, 13125 Berlin
In Germany only about 20 percent of start-ups are founded by women. Despite progress, women still face numerous hurdles and prejudices when venturing into entrepreneurship. Successful female founders from the Campus Berlin-Buch share their experiences, how they have been able to move from thriving research backgrounds into the world of successful Life Science Entrepreneurship.
• What experiences have these entrepreneurs gained?
• What support have they received and from whom?
• Are there specific recommendations that can benefit other female founders?
• Last but not least: What advantages – or challenges – do these women see when contemplating their own entrepreneurial journey?
Dr. Stefanie Reichelt, with over 20 years of experience as a scientist and coach in the UK start-up scene and climate entrepreneurship (Carbon13), will engage in conversation with
- Dr. Anthea Wirges, Chief Operating Officer and co-founder at CARTemis Therapeutics GmbH, a spin-off from the Max Delbrück Center that wants to use novel CAR T-cell therapies to help patients with cancers that are currently untreatable,
- Dr. Elisa Kieback, CTO and co-founder at t-knife Therapeutics, a biopharmaceutical company located on the Campus Berlin-Buch dedicated to developing novel therapeutics to fight cancer, initially focused on T cell receptor (TCR) engineered T cell therapies (TCR-Ts),
- Dr. Lucile Bonnin, Cambrium GmbH Head of Research & Development at Cambrium, a next-generation materials company utilizing the molecular programmability of proteins to create new, sustainable products,
- Dr. Merle Fuchs, CEO and Co-Founder at Pramomolecular, a spin-off from the TU Berlin developing an innovative class of drugs that can efficiently down-regulate disease-causing proteins,
- Dr. Petya Jordan, Coordinator PostDoc Center Adlershof at the Humboldt University of Berlin supports postdocs in their career development, both individually and as groups.
Be part of this inspiring conversation and be inspired by the experiences and insights of successful women in entrepreneurship. Feminine entrepreneurship – a discussion that sparks inspiration and paves the way for future women entrepreneurs.
Followed by Get together and Networking over snacks and drinks.
-------------------------------------------
Other topics planned for this year:
- Drug approvals in oncology - a critical assessment (11 April 2024)
- Sustainability in the laboratory 4.0 (May 2024)
- The journey of company... "Founder stories"
- Team 4.0 - Networked working in biotechnology
- Life Science Marketing: A potential way of scientist to promote their products
- CROs in diagnostics and therapeutics development
-----------------------------------
Further information:
Uwe Lohmeier u.lohmeier@campusberlinbuch.de
